RxDoctor Payments Data

Bruce Berger

Internal Medicine · Brooklyn, NYNPI 1821361395

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,361,113 of the $3,362,570 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Otsuka Pharmaceutical Development & Commercialization, Inc.. Reporting peaked in 2021 at $761,388 and has fallen 52.9% since, to $358,275 in 2025. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,362,570in general payments, 2019–2025

Across 101 payments — averaging $33,293 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$3.4M
$87in research payments, 2019–2025

Across 1 payment — averaging $87.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$87

What the payments were for

  • Consulting fees$3,361,113100%
  • Travel & lodging$1,3890%
  • Food & beverage$690%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,362,570 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Other internal medicine in Brooklyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →